Guardant Health Inc (GH)
23.56
-1.20
(-4.86%)
USD |
NASDAQ |
May 21, 16:00
23.56
0.00 (0.00%)
After-Hours: 17:21
Guardant Health Cash from Investing (Quarterly): 28.07M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 28.07M |
December 31, 2023 | 663.45M |
September 30, 2023 | 260.70M |
June 30, 2023 | -241.13M |
March 31, 2023 | 157.22M |
December 31, 2022 | 70.63M |
September 30, 2022 | 41.27M |
June 30, 2022 | -72.89M |
March 31, 2022 | 110.81M |
December 31, 2021 | -266.70M |
September 30, 2021 | -47.39M |
June 30, 2021 | 127.07M |
March 31, 2021 | 123.87M |
Date | Value |
---|---|
December 31, 2020 | -297.68M |
September 30, 2020 | -14.66M |
June 30, 2020 | -325.55M |
March 31, 2020 | 20.80M |
December 31, 2019 | 23.36M |
September 30, 2019 | -35.73M |
June 30, 2019 | -320.53M |
March 31, 2019 | 15.33M |
December 31, 2018 | -197.69M |
September 30, 2018 | 24.46M |
June 30, 2018 | 11.72M |
March 31, 2018 | 8.47M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-325.55M
Minimum
Jun 2020
663.45M
Maximum
Dec 2023
0.2496M
Average
22.08M
Median
Cash from Investing (Quarterly) Benchmarks
Exact Sciences Corp | -171.44M |
Illumina Inc | -48.00M |
Delcath Systems Inc | 4.66M |
CytoSorbents Corp | -0.127M |
Progyny Inc | 19.34M |
Cash from Investing (Quarterly) Related Metrics
Cash from Operations (Quarterly) | -30.28M |
Cash from Financing (Quarterly) | -1.074M |
Free Cash Flow | -300.71M |
Free Cash Flow Per Share (Quarterly) | -0.3058 |
Free Cash Flow to Equity (Quarterly) | -37.86M |
Free Cash Flow to Firm (Quarterly) | -37.22M |
Free Cash Flow Yield | -10.93% |